With a Ph.D. in Physics, Daniel Thomas (66) is Professor at the University of Technology of Compiègne, Chairman of the Scientific ADRIA Development, Director of Studies at the Ecole Pratique des Hautes Etudes in Paris and member of the Academy of Technology.
He is also Chairman of the competitiveness cluster "Industries and Agro-resources" and the Regional Agency for Innovation in Picardie (Picardy ARI) in France.
Daniel Thomas is director of the company METabolic Explorer, a French biological chemistry listed on NYSE Euronext in Paris.
In addition to his appointment, Daniel Thomas says, "I am very pleased to be able to contribute to the emergence of a new player in the French biotech industry.
has already successfully completed a number of key steps and demonstrates its ability to combine a high level of research and development with an ability to deal with industrial and commercial issues by signing partnership agreements with leading players.
“I am convinced that Fermentalg has everything it takes to become the European leader in the field of bio transformation from microalgae."
Created in 2009 by Pierre Calleja, Fermentalg is a biotechnology company specializing in the industrial production of bio-chemical molecules by microalgae.
This proprietary technology combined with its rich seed bank allows it to target diverse markets ranging from animal feed to specialty chemistry through nutrition and biofuels.
Fermentalg is supported by investment funds including senior CEA Investments, Demeter Partners and Emertec.